Sort
4,870 grants matching “glp 1”
Therapeutic APOE2 overexpression for early Alzheimer's disease
$1,802,422Beverly L Davidson · Children'S Hosp Of Philadelphia · U01 · FY2022 · NS
IND-Enabling Pre-Clinical Studies to Accelerate the Clinical Development of a Humanized Anti-Cocaine Monoclonal Antibody
$1,796,316Andrew B Norman · University Of Cincinnati · U01 · FY2019 · DA
TRIP-PCI: PAR1 Pepducin-Based Interventions in Arterial Thrombosis
$1,794,671Athan Kuliopulos · Tufts Medical Center · P50 · FY2016 · HL
Elafin Therapy for Pulmonary Arterial Hypertension
$1,790,971Marlene Rabinovitch · Stanford University · P01 · FY2017 · HL
Southeast Translational Alcohol and HIV Research Center (STAHR Center)
$1,785,057Matthew S Freiberg · Vanderbilt University Medical Center · P60 · FY2025 · AA
Translational Gene Therapy for CNGB1 Retinitis Pigmentosa
$1,783,428Simon Petersen-Jones · Michigan State University · R24 · FY2019 · EY
HIV Reservoir Dynamics Associated with Metabolic Complications of HIV Infection
$1,778,953Timothy W Schacker · University Of Minnesota · R01 · FY2025 · DK
First-In-Human Study of a Humanized Anti-Cocaine Monoclonal Antibody
$1,777,952Andrew B Norman · University Of Cincinnati · U01 · FY2021 · DA
Completion of IND-package for a novel, non-narcotic painkiller
$1,776,585Ajay S Yekkirala · Blue Therapeutics, Inc. · R44 · FY2020 · DA
Small Molecule Inhibitors of Smallpox Virus Replication
$1,751,533Robert Jordan · Siga Technologies, Inc. · R44 · FY2007 · AI
IND-Enabling Pre-clinical Development of Modified P8 for the Treatment of Alzheimer's Disease
$1,750,000Nazneen N Dewji · Cenna Biosciences, Inc. · R44 · FY2020 · AG
Evaluation of Optimized Lead Candidates for Encephalitic Alphaviruses in Animal Models
$1,747,217Colleen B Jonsson · University Of Tennessee Health Sci Ctr · U19 · FY2020 · AI
Elafin Therapy for Pulmonary Arterial Hypertension
$1,729,729Marlene Rabinovitch · Stanford University · P01 · FY2021 · HL
Elafin Therapy for Pulmonary Arterial Hypertension
$1,729,729Marlene Rabinovitch · Stanford University · P01 · FY2020 · HL
Elafin Therapy for Pulmonary Arterial Hypertension
$1,728,355Marlene Rabinovitch · Stanford University · P01 · FY2019 · HL
Development of a Novel Resolvin-Based Therapy for Treatment of Pancreatic Cancer
$1,725,203John Parkinson · Thetis Pharmaceuticals, Llc · R44 · FY2025 · CA
A Humanized Monoclonal FSH Blocking Antibody for Alzheimer's Disease
$1,712,573Mone Zaidi · Icahn School Of Medicine At Mount Sinai · U01 · FY2021 · AG
rAAV-CNGB3 Gene Therapy for Achromatopsia: Translational Research Studies
$1,707,387William W Hauswirth · University Of Florida · R24 · FY2014 · EY
Enhancing Chimeric Antigen Receptor T Cell Therapies for Hematologic Malignancies: Beyond CART 19
$1,701,970Carl H. June · University Of Pennsylvania · P01 · FY2020 · CA
Evaluation of a dual PPAR agonist for treatment of Alzheimer's disease
$1,692,440James Cardelli · Oleolive, Inc. · R42 · FY2022 · AG
Direct protein phosphatase 2A (PP2A) activators as novel Alzheimerâs Disease (AD) therapeutics
$1,688,077Michael Ohlmeyer · Atux Iskay Group Llc · R44 · FY2024 · AG
Salivary Gland Secretion Mechanisms During Normal And Altered Functional States
$1,681,211Bruce J Baum · National Institute Of Dental & Craniofacial Research · ZIA · FY2011 · DE
Therapeutic APOE2 overexpression for early Alzheimer's disease
$1,681,128Beverly L Davidson · Children'S Hosp Of Philadelphia · U01 · FY2019 · NS
PASSIVE IMMUNITY TO COCAINE USING NOVEL HUMAN ANTIBODIES
$1,671,351University Of Cincinnati · U19 · FY2001 · DA
rAAV-CNGB3 Gene Therapy for Achromatopsia: Translational Research Studies
$1,663,014William W Hauswirth · University Of Florida · R24 · FY2016 · EY